Skip to content
Screener

CareDx CDNA Operating Cash Flow

Operating Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.13B+51.9%
Natera, Inc. logo
Natera, Inc.NTRA
$54.79M+45.8%
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
-$7.64M-30.8%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$22.48M-25.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$7.1M+260%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$108.1M-16.8%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.32B+218%
Enterprise value$2.26B+228%
P/S5.6×+3.5×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: CareDx’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001217234-26-000033
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Accounts payable(338)377
Accrued compensation(17,810)(24,082)
Accrued and other liabilities10,3726,308
Net cash provided by (used in) operating activities4,333(26,584)
Investing activities:
Purchases of marketable securities(39,850)(52,472)
Maturities of marketable securities54,72855,427
Additions of property and equipment(3,819)(1,630)

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is CareDx's operating cash flow?
CareDx (CDNA) reported operating cash flow of $4.33M in Q1 2026.
How has CareDx's operating cash flow changed year-over-year?
CareDx's operating cash flow increased by 116.3% year-over-year, from -$26.58M to $4.33M.
What is the long-term trend for CareDx's operating cash flow?
Over 2 years (2023 to 2025), CareDx's operating cash flow has grown at a 51.2% compound annual growth rate (CAGR), from -$18.39M to $42.03M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about CareDx's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude